Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta‐analysis
Reza Parvan, Milad Hosseinpour, Yousef Moradi, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2212-2225
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 31
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
Elisabeth A. Jalink, Amber W. Schonk, Reinier A. Boon, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 8
Altered microRNA Expression Correlates with Reduced TLR2/4-Dependent Periodontal Inflammation and Bone Resorption Induced by Polymicrobial Infection
Syam Praveen Kumar Jeepipalli, Parvathi Gurusamy, A. Martins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure
Aferdita Spahillari, Laurel Jackson, Dimitrios Varrias, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 3, pp. 1400-1410
Open Access | Times Cited: 6
Circular RNA regulatory role in pathological cardiac remodelling
Alessia Bibi, Monika Barteková, Shrey Gandhi, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 5
DEPDC1B, CDCA2, APOBEC3B, and TYMS are potential hub genes and therapeutic targets for diagnosing dialysis patients with heart failure
Wenwu Tang, Zhixin Wang, Xinzhu Yuan, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients
Chiara Galbiati, Vincenzo Dattilo, Marco Bortolomasi, et al.
Journal of Ect (2025)
Closed Access
Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study
Rachel M. Wald, George Tomlinson, Christopher A. Caldarone, et al.
Journal of the American Heart Association (2025)
Open Access
Modeling heart failure by induced pluripotent stem cell-derived organoids.
Irene Bissoli, Francesco Alabiso, Cristina Cosentino, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167861-167861
Closed Access
Small extracellular vesicles associated miRNA in myocardial fibrosis
Minwen Long, Min Cheng
Biochemical and Biophysical Research Communications (2024) Vol. 727, pp. 150336-150336
Open Access | Times Cited: 3
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3109-3109
Open Access | Times Cited: 7
Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities—Role of microRNAs
Xiao‐Nan Li, Min Sun, Zhe Wang, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 3
Open Access | Times Cited: 6
Heart Failure: Is There an Ideal Biomarker?
Giuseppe Clemente, John Sebastian Soldano, Antonino Tuttolomondo
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 11
Open Access | Times Cited: 5
Current Insights and Future Directions in the Treatment of Heart Failure with Preserved Ejection Fraction
Roxana Mihaela Chiorescu, Roxana-Daiana Lazar, Alexandru Ruda, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 440-440
Open Access | Times Cited: 4
Pharmacological and molecular mechanisms of miRNA-based therapies for targeting cardiovascular dysfunction
Alejandro Gonzaléz‐Candia, Esteban G. Figueroa, Bernardo J. Krause
Biochemical Pharmacology (2024) Vol. 228, pp. 116318-116318
Closed Access | Times Cited: 1
Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier
Ana-Maria Vrabie, Stefan Totolici, Caterina Delcea, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4627-4627
Open Access | Times Cited: 1
Extracellular Vesicle-Derived Non-Coding RNAs: Key Mediators in Remodelling Heart Failure
Jiayi Zhao, Huang Huang
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9430-9448
Open Access | Times Cited: 1
A target-triggered colorimetric sensor for ultrasensitive detection of miRNAs based on self-powered three-dimensional DNA walker
Yingxue Li, Tingrui Zhang, Gang Bai, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135370-135370
Closed Access | Times Cited: 1
Diagnostic and prognostic value of microRNA423-5p in patients with heart failure
Xiaohua Guo, Yi Zhou, Honghao Huang, et al.
Journal of Cardiothoracic Surgery (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Current Review of Heart Failure-Related Risk and Prognostic Factors
Michał Maksymilian Wilk, Jakub Wilk, Szymon Urban, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2560-2560
Open Access | Times Cited: 1
Predicting the molecular mechanisms of cardiovascular toxicity induced by per- and polyfluoroalkyl substances: an In Silico network toxicology perspective
Fuat Karakuş, Burak Kuzu
Toxicology Research (2024) Vol. 13, Iss. 6
Closed Access | Times Cited: 1
Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 7, pp. 509-518
Closed Access | Times Cited: 3
Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis
Samuel R. Olson, W.H. Wilson Tang, Chia‐Feng Liu
Current Heart Failure Reports (2024) Vol. 21, Iss. 3, pp. 262-275
Open Access
Diagnostic and prognostic value of microRNA423-5p in patients with heart failure
Xiaohua Guo, Yi Zhou, Honghao Huang, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top